Translational genomics and combinatorial drug discovery to improve outcomes for patients with colorectal cancer
Translational genomics and combinatorial drug discovery to improve outcomes for patients with colorectal cancer
批准号:
nhmrc : 1136119
负责人:
A/Pr Oliver Sieber
金额:
$43.29万
依托单位国家:
澳大利亚
项目类别:
Research Fellowships
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 2022-12-31
中文摘要
肠癌是澳大利亚一个主要的公共卫生负担。在接下来的5年里,A/ Sieber教授的研究将集中在了解肠癌的分子病理学以及这如何决定疾病的进程和对治疗的反应。整合基因组,功能和药物发现研究将为基础肿瘤生物学提供重要的新见解,并为诊断和治疗开辟新的途径。
英文摘要
Bowel cancer is a major public health burden in Australia. Over the next 5 years, A/Prof Sieber’s research will focus on understanding the molecular pathology of bowel cancer and how this determines the course of disease and response to therapy. Integrated genomic, functional and drug discovery studies will provide significant new insights into fundamental tumour biology and open up new avenues for diagnosis and treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Personalisation of Aspirin Adjuvant Therapy in Patients with Colorectal Cancer
-
批准号:nhmrc : GNT1138047
-
项目类别:Project Grants
-
资助金额:$76.26万
-
财政年份:2018
-
负责人:A/Pr Oliver Sieber
-
依托单位:
Translational genomics and combinatorial drug discovery to improve outcomes for patients with colorectal cancer
-
批准号:nhmrc : GNT1136119
-
项目类别:Research Fellowships
-
资助金额:$64.02万
-
财政年份:2018
-
负责人:A/Pr Oliver Sieber
-
依托单位:
Personalisation of Aspirin Adjuvant Therapy in Patients with Colorectal Cancer
-
批准号:nhmrc : 1138047
-
项目类别:Project Grants
-
资助金额:$51.56万
-
财政年份:2018
-
负责人:A/Pr Oliver Sieber
-
依托单位:
Role of the EHF transcription factor in regulating the differentiation status of colon cancers
-
批准号:nhmrc : GNT1107831
-
项目类别:Project Grants
-
资助金额:$62.2万
-
财政年份:2016
-
负责人:A/Pr Oliver Sieber
-
依托单位:
Role of the EHF transcription factor in regulating the differentiation status of colon cancers
-
批准号:nhmrc : 1107831
-
项目类别:Project Grants
-
资助金额:$42.63万
-
财政年份:2016
-
负责人:A/Pr Oliver Sieber
-
依托单位:
Population genetics and functional genomics approaches to improve outcomes for patients with colorectal cancer
-
批准号:nhmrc : 1062226
-
项目类别:Career Development Fellowships
-
资助金额:$31.11万
-
财政年份:2014
-
负责人:A/Pr Oliver Sieber
-
依托单位:
Overcoming resistance to anti-EGFR antibody therapy in colorectal cancer using novel targeted PI3K and MEK inhibitors
-
批准号:nhmrc : 1050177
-
项目类别:Project Grants
-
资助金额:$31.11万
-
财政年份:2013
-
负责人:A/Pr Oliver Sieber
-
依托单位:
国内基金
海外基金
登录
查看更多内容
联合基因组重测序和10× Genomics scRNA-Seq解析乌骨鸡胸肌黑色素转运的分子机制
-
批准号:32072711
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:郭松长
-
依托单位:
Journal of Genetics and Genomics
-
批准号:31224803
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:于昕
-
依托单位:
病理性瘢痕的相关基因及siRNA干扰机制的研究
-
批准号:30471790
-
项目类别:面上项目
-
资助金额:21.0万元
-
批准年份:2004
-
负责人:王春梅
-
依托单位:
蛋鸡与肉鸡骨骼肌生长发育差异的分子遗传学基础
-
批准号:30330430
-
项目类别:重点项目
-
资助金额:130.0万元
-
批准年份:2003
-
负责人:朱大海
-
依托单位: